Krilogy Financial’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q4
Sell
-2,104
Closed -$188K 835
2018
Q3
$188K Sell
2,104
-1,125
-35% -$99.4K 0.04% 150
2018
Q2
$256K Sell
3,229
-121
-4% -$10K 0.06% 120
2018
Q1
$299K Buy
3,350
+50
+2% +$4.8K 0.07% 123
2017
Q4
$344K Sell
3,300
-222
-6% -$25K 0.08% 108
2017
Q3
$514K Sell
3,522
-18
-0.5% -$2.45K 0.13% 74
2017
Q2
$460K Buy
3,540
+1,395
+65% +$171K 0.13% 72
2017
Q1
$248K Hold
2,145
0.08% 112
2016
Q4
$248K Buy
2,145
+1,100
+105% +$123K 0.08% 112
2016
Q3
$109K Sell
1,045
-1,150
-52% -$124K 0.03% 198
2016
Q2
$216K Hold
2,195
0.08% 115
2016
Q1
$220K Buy
+2,195
New +$226K 0.09% 100
2015
Q4
Sell
-1,595
Closed -$173K 661
2015
Q3
$173K Buy
+1,595
New +$198K 0.08% 94

Other funds holding CELG

Krilogy Financial's CELG Position: Q4 2018 in Review

Krilogy Financial sold out of Celgene Corp (CELG) in Q4 2018, closing a stake of 2,104 shares — an estimated $188K sold.

Krilogy Financial first reported a position in CELG in Q3 2015 and held it in 12 quarters. The position peaked at $514K in Q3 2017. 1,317 funds tracked by Wall St. Rank hold CELG as of Q4 2018.

  • Krilogy Financial reported no remaining Celgene Corp position as of Q4 2018 after selling out during the quarter.
  • Krilogy Financial sold 2,104 Celgene Corp shares in Q4 2018, an estimated $188K.
  • Krilogy Financial first reported a position in Celgene Corp in Q3 2015 and held it in 12 quarters.
  • Krilogy Financial's Celgene Corp position peaked at $514K in Q3 2017.
  • 1,317 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2018.

Based on Krilogy Financial's 13F filing for Q4 2018, filed 14 Feb 2019.